Start 30 days free, no card. Full Pro access for a month, then decide. Start free
Analyst
Mirza Baig
Period: Reporting periods mapped to calendar 2025 Q2 – 2025 Q4 (3 quarters).
- Questions
- 5on tracked calls
- Challenge rate
- 20%1 of 5 questionsLimited sample
- Companies
- 1questioned at least once
- Reporting periods
- 3with questions
These figures cover the whole profile: every tracked question, all reporting periods.
How to read these numbers
Challenge rate is the share of questions that pushed back, pressed for specifics or questioned management’s assumptions. It describes how questions were asked on the calls tracked here; it does not measure whether any view turned out to be right.
Rounding. Rates are rounded to whole percentages, so a small share can show as 0% even when some questions were challenging. The count beside each rate is exact; “none of N questions” means no question was challenging.
No questions recorded. “—” means there is nothing to calculate: no questions were recorded for that period on the calls tracked here. It does not mean there was no activity.
Fewer than 3 questions. A company-level rate is withheld when fewer than 3 questions were recorded for that company; the questions are still counted everywhere else.
Small samples. Profiles with fewer than 10 questions are marked Limited sample.
Reporting periods. Questions are grouped by the calendar quarter each company’s fiscal reporting period maps to, not by the date of the call. Periods without a calendar mapping are listed separately under their fiscal label.
Questions asked
Grouped by company, most questions first. Open a company to read its questions, newest reporting period first.
Showing 5 of 5 questions from 1 company
MOAltria5 questions · 3 reporting periods · 1 of 5 challenging
Calendar 2025 Q4
I calculate there were 14.5% in the quarter and that sort of compares to a nine-month run rate of 9.5%
Show response
Sal confirmed elevated costs predominantly from import-export manufacturing investments including different pack configurations and track-and-trace capabilities.
Do I understand that you will be national with ON PLUS in the first half of this year
Show response
Billy confirmed national launch in first half 2026. Noted messy early period with launch, halt for FDA pilot, then resume. Consumer feedback on differentiation in mouthfeel and flavor is positive.
Calendar 2025 Q3
Should this be the amount that we think about the potential benefit from the duty drawbacks
Show response
Billy cautioned against overestimating duty drawback. Regarding FDA pilot, management will make decisions based on long-term company interest. Pilot program in pouches seen as learning opportunity.
Could you clarify that the EPS growth is suggested to accelerate to high single digits over the next couple of years
Show response
Billy confirmed mid-single digit CAGR goal is unchanged and that is how they are managing the business going forward.
Calendar 2025 Q2
whether the net impact of the import restrictions versus the product still coming through mislabeling is having a neutral impact or a positive impact
Show response
Billy noted too soon to call it a trend. Enforcement is upstream at import/wholesale, unclear if consumer has felt it at retail yet. Mislabeling adds another layer of illegality.
Challenge rate by company
Every company this analyst questioned, most questions first. A company-level rate is shown from 3 questions; below that it is withheld.
| Company | Questions | Challenge rate |
|---|---|---|
| MO Altria | 5 | 20%1 of 5 questions |
- MOAltria · 5 questions20%1 of 5 questions
Activity by reporting period
Questions recorded for each calendar quarter that companies’ reporting periods map to (not the call date), with the challenge rate for that period. Periods inside the range with no questions are shown as “No questions recorded”.
| Calendar period | Questions | Challenge rate | Companies |
|---|---|---|---|
| 2025 Q2 | 1 | 0%none of 1 question | 1 |
| 2025 Q3 | 2 | 50%1 of 2 questions | 1 |
| 2025 Q4 | 2 | 0%none of 2 questions | 1 |
- 2025 Q21 question · challenge rate 0% (none of 1 question) · 1 company
- 2025 Q32 questions · challenge rate 50% (1 of 2 questions) · 1 company
- 2025 Q42 questions · challenge rate 0% (none of 2 questions) · 1 company
Topics
Topics tagged on this analyst’s questions.
- Regulation Policy2
- Cost Pressure1
- Margin1
- Product Launch1
- Capital Allocation1
- Guidance Reliability1
- Competitive Dynamics1